Moneycontrol PRO
you are here: HomeNewsAbbott india
abbott india
Jump to
104 Results Found
  • Buy Abbott India, target Rs 8,450: Dharmesh Shah Dec 27, 2018 12:11 PM IST

    Buy Abbott India, target Rs 8,450: Dharmesh Shah

    We expect the stock to resume fresh up move and test levels of Rs 8450 levels in the medium term, says Dharmesh Shah of ICICI Securities.

  • Abbott India Standalone September 2018 Net Sales at Rs 979.72 crore, up 5.24% Q-o-Q Nov 14, 2018 10:02 AM IST

    Abbott India Standalone September 2018 Net Sales at Rs 979.72 crore, up 5.24% Q-o-Q

  • Abbott India Q2 net profit up marginally at Rs 137.68 cr Nov 13, 2018 10:38 PM IST

    Abbott India Q2 net profit up marginally at Rs 137.68 cr

    Revenue from operations stood at Rs 979.72 crore for the quarter under consideration against Rs 930.98 crore for the same period a year ago.

  • Hold Abbott India; target of Rs 7250: Centrum Oct 11, 2018 05:18 PM IST

    Hold Abbott India; target of Rs 7250: Centrum

    Centrum recommended hold rating on Abbott India with a target price of Rs 7250 in its research report dated October 10, 2018.

  • Abbott India lines up 100 product launches over the next 5 years Aug 26, 2018 12:07 PM IST

    Abbott India lines up 100 product launches over the next 5 years

    The Mumbai-based firm, which is a subsidiary of US-based Abbott Laboratories, had launched 21 new products in the country last fiscal.

  • Buy Abbott India; target of Rs 7530: Centrum May 23, 2018 03:58 PM IST

    Buy Abbott India; target of Rs 7530: Centrum

    Centrum is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 7530 in its research report dated May 15, 2018.

  • Corona Remedies acquires two brands from Abbott Apr 02, 2018 05:30 PM IST

    Corona Remedies acquires two brands from Abbott

    Both these brands are popular prescription drugs to manage diabetes and hyperthyroidism, Tejas Kothari, Head-Strategy at Corona said.

  • Abbott India Q2 profit up 83% at Rs 137.52 cr Nov 13, 2017 01:46 PM IST

    Abbott India Q2 profit up 83% at Rs 137.52 cr

    It had posted a net profit of Rs 75.02 crore for the corresponding period of last fiscal, Abbott India said in a filing to BSE.

  • Nifty likely to open higher; buy Abbott India, La Opala: Prakash Gaba Oct 03, 2017 07:57 AM IST

    Nifty likely to open higher; buy Abbott India, La Opala: Prakash Gaba

    According to Technical Analyst Prakash Gaba of prakashgaba.com, expect a gap up opening with crucial support for the Nifty at 9596 and resistance at 9816-9946. On the other hand Bank Nifty has support at 23720 and resistance at 24312.

  • Abbott India Q1 net profit down 35% at Rs 48 cr Aug 08, 2017 03:19 PM IST

    Abbott India Q1 net profit down 35% at Rs 48 cr

    The company had posted net profit of Rs 74.01 crore in the same quarter last fiscal, Abbott India said in a BSE filing.

  • Top 10 stocks which slipped up to 60% in Nifty 500 index in FY17 Mar 31, 2017 01:29 PM IST

    Top 10 stocks which slipped up to 60% in Nifty 500 index in FY17

    Just Dial lost nearly 30 per cent, followed by Wockhardt which dropped 25 percent, Reliance Communication slipped 22 percent, and Tata Elxsi plunged 21 percent in the same period.

  • 634 drugs on NPPA's price ceiling non-compliant list Feb 23, 2017 09:10 PM IST

    634 drugs on NPPA's price ceiling non-compliant list

    As many as 634 drugs of various strengths produced by firms, including Cipla, Abbott, Astrazeneca and Dr Reddy's, are "suspected" to be non-compliant with ceiling prices as notified by NPPA.

  • Buy Abbott India; target of Rs 5380: Centrum Feb 10, 2017 03:05 PM IST

    Buy Abbott India; target of Rs 5380: Centrum

    Centrum is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 5380 in its research report dated February 06, 2017.

  • Abbott India Q3 net up 26% at Rs 85.56 cr Feb 06, 2017 02:14 PM IST

    Abbott India Q3 net up 26% at Rs 85.56 cr

    Its standalone total income from operations also rose to Rs 755.72 crore during the quarter from Rs 669.52 crore in the same period a year ago.

  • Q3 results: Five trends to watch out from Indian drugmakers Jan 14, 2017 02:00 PM IST

    Q3 results: Five trends to watch out from Indian drugmakers

    Analysts predict Q3 to be a tough quarter with revenue growth moderating to 11.7 percent in October-December period compared to 18.4 percent compounded annual growth rate (CAGR) over last 10 years

  • Indian drug market growth moderates to 7.2% in December Jan 09, 2017 08:18 PM IST

    Indian drug market growth moderates to 7.2% in December

    The domestic drug market grew at 7.2 percent in December, compared to 15.5 percent growth in November due to slowdown in uptake of chronic portfolio and contraction in acute segment. The pharma market clocked Rs.9.132 crores in December.

  • Stocks in news: Axis, Tata Motors, Sun Pharma, IRB, Fortis, MEP Dec 13, 2016 08:01 AM IST

    Stocks in news: Axis, Tata Motors, Sun Pharma, IRB, Fortis, MEP

    Axis Bank | Tata Motors | Sun Pharma | IRB Infrastructure | Sunteck Realty | NIIT | Fortis Healthcare | Abbot India | APL Apollo Tubes | Aarey Drugs | PAE | MEP Infra and Bajaj Finance are stocks, which are in the news today.

  • Hold Abbott India; target of Rs 4480: Centrum Dec 01, 2016 10:37 AM IST

    Hold Abbott India; target of Rs 4480: Centrum

    Centrum recommended hold rating on Abbott India with a target price of Rs 4480 in its research report dated November 28, 2016.

  • Stocks in news: Cipla, GAIL, Tata Elxsi, Aurobindo, Ricoh, Uflex Nov 28, 2016 08:01 AM IST

    Stocks in news: Cipla, GAIL, Tata Elxsi, Aurobindo, Ricoh, Uflex

    Bharti Airtel | Cipla | GAIL | Idea Cellular | Apollo Tyres | Tata Elxsi | Aurobindo Pharma | Uflex | Dilip Buildcon | ARSS Infra | GPT Infra | Strides Shasun | Ashok Leyland and Ricoh India are stocks, which are in the news today.

  • Abbott India Q2 PAT seen up 4.7% to Rs 77.5 cr: Centrum Oct 19, 2016 02:34 PM IST

    Abbott India Q2 PAT seen up 4.7% to Rs 77.5 cr: Centrum

    Net Sales are expected to increase by 2 percent Q-o-Q (up 16.7 percent Y-o-Y) to Rs 752.5 crore, according to Centrum.

  • Abbott India names Ambati Venu as MD Sep 29, 2016 01:00 PM IST

    Abbott India names Ambati Venu as MD

    "The board at its meeting held today approved the appointment of Ambati Venu as an additional director on the board and managing director of the company for a term of 5 years effective September 29, 2016, subject to approval from the central government and shareholders of the company," Abbott India said in a BSE filing.

  • Abbott India Q1 net up 10% at Rs 74 cr Aug 26, 2016 06:32 PM IST

    Abbott India Q1 net up 10% at Rs 74 cr

    The company had posted a net profit of Rs 67.31 crore for the similar quarter last year, Abbott said in a BSE filing.

  • Stocks in news: Tata Motors, DLF, Guj Gas, Indian Hotels, Ricoh Jul 08, 2016 08:01 AM IST

    Stocks in news: Tata Motors, DLF, Guj Gas, Indian Hotels, Ricoh

    Tata Motors | DLF | Tata Steel | Gujarat Gas | Sobha | Aurobindo Pharma | Mahindra Holidays | Lupin | Palred Tech | Ricoh India | Astec | Garware Wall Ropes | Indian Hotels | MMTC | GTL Infra Projects | Viji Financehjmun | Vedanta | Hanung Toys | Indo Count and Zee Learn are stocks, which are in the news today.

  • Stocks in news: Tata Steel, L&T, NALCO, GAIL, Monsanto, ITC, VRL May 26, 2016 08:14 AM IST

    Stocks in news: Tata Steel, L&T, NALCO, GAIL, Monsanto, ITC, VRL

    Tata Steel | Larsen and Toubro | Kaveri Seed | Monsanto | KNR Construction | Ruchi Soya | VRL Logistics | NALCO | IL&FS Transportation | Power Grid and GAIL are stocks, which are in the news today.

  • Abbott India Q4 net up 18.58% at Rs 59-cr May 25, 2016 09:22 PM IST

    Abbott India Q4 net up 18.58% at Rs 59-cr

    Drug firm Abbott India today reported an 18.58 per cent rise in its standalone net profit to Rs 59.01 crore for the fourth quarter ended March 2016, mainly on account of robust sales.

Sections
ISO 27001 - BSI Assurance Mark